Optogenetic RNA relocalization reveals causal neural function in vivo
En palabras de los autores
RNA localization dictates where translation occurs, yet its disease role is unclear because most assays manipulate abundance, not position. We develop an optogenetic CRISPR-dCas13 system (Opto-CRISPR-TO) that repositions endogenous RNAs with subcellular precision, second-scale kinetics, and reversibility, enabling causal tests in vivo. In cells, Opto-CRISPR-TO routes diverse RNAs to organelles and ribonucleoprotein granules with multiplex, bidirectional control, revealing distinct RNA behaviors in centrosomes and P-bodies. In mouse retina, acute (4-hour) mislocalization of Actb mRNA redirects {beta}-actin protein, remodels synaptic architecture and cell positioning, and persistently impairs vision. Thus, RNA location governs proteome topology and neural circuit output, and brief mislocalization drives lasting dysfunction. The approach generalizes across targets, compartments, and cell types, establishing a framework for probing RNA localization mechanisms in development, plasticity, and degeneration.
Apareció: jueves, 19 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.